Bausch & Lomb Files Q1 2025 10-Q
Ticker: BLCO · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1860742
Sentiment: neutral
Topics: 10-Q, financials, ophthalmic-goods
TL;DR
**Bausch & Lomb Q1 2025 10-Q filed. Financials look steady.**
AI Summary
Bausch & Lomb Corp filed a 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and segment information are presented, reflecting the company's ongoing business activities in the ophthalmic goods sector.
Why It Matters
This filing provides investors with the latest financial snapshot of Bausch & Lomb, crucial for understanding the company's performance and outlook in the competitive ophthalmic market.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Players & Entities
- Bausch & Lomb Corp (company) — Filer of the 10-Q
- 20250331 (date) — Period of report
- 20250430 (date) — Filing date
- 0001860742 (company) — Central Index Key for Bausch & Lomb Corp
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20250430.
What is Bausch & Lomb Corp's Central Index Key (CIK)?
Bausch & Lomb Corp's Central Index Key is 0001860742.
What is the Standard Industrial Classification (SIC) code for Bausch & Lomb Corp?
The SIC code is 3851, which corresponds to Ophthalmic Goods.
What is the fiscal year end for Bausch & Lomb Corp?
The fiscal year end for Bausch & Lomb Corp is 1231.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding Bausch & Lomb Corp (BLCO).